Overcoming challenges to develop technology for child health.

Children health innovation technology young people

Journal

Journal of medical engineering & technology
ISSN: 1464-522X
Titre abrégé: J Med Eng Technol
Pays: England
ID NLM: 7702125

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 23 6 2022
medline: 14 9 2022
entrez: 22 6 2022
Statut: ppublish

Résumé

Millions of children and young people (CYP) in the UK are affected by chronic or rare health conditions. Rapid advances in science and technology have resulted in CYP with chronic and rare conditions now surviving well into adulthood. New technologies have the potential to improve short- and long-term health outcomes for CYP with health conditions, prevent adult onset disease and complications, and reduce the burden on health services. There is thus a need for targeted investment and appropriate governance in child health technology development to address the specific needs of this population; health technology must be versatile to meet the social, anatomical, cognitive, psychological, and physiological changes inherent to childhood development. Despite the growing demand for health technology for a sizeable global population, industry still wrongly perceives the market size is relatively small, and health technology development is often localised and fragmented with limited scope for spread and adoption. These challenges can be overcome by validating and prioritising unmet needs, involving CYP and their families throughout the innovation pathway, facilitating effective partnerships with key stakeholders, and utilising national and international infrastructure and networks. This paper outlines five innovations supported by NIHR Children and Young People MedTech Co-operative that illustrate how common challenges in child health technology development can be overcome. It is essential that we continue to address such challenges and invest in the health and wellbeing of CYP.

Identifiants

pubmed: 35730496
doi: 10.1080/03091902.2022.2089254
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

547-557

Auteurs

Nathaniel Mills (N)

NIHR Children and Young People MedTech Co-operative, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Philippa Howsley (P)

NIHR Children and Young People MedTech Co-operative, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

Clare M Bartlett (CM)

NIHR Children and Young People MedTech Co-operative, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

Linda Olubajo (L)

Sheffield Business School, Sheffield Hallam University, Sheffield, UK.

Paul Dimitri (P)

NIHR Children and Young People MedTech Co-operative, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH